<DOC>
	<DOC>NCT02975284</DOC>
	<brief_summary>This study evaluates the longterm clinical outcomes, including safety and efficacy parameters after Bronchial Thermoplasty (BT) treatment over a period of 5 years. All patients included in de TASMA trial in the Netherlands will be asked to participate in the TASMA extension study.</brief_summary>
	<brief_title>Unraveling Targets of Therapy in Bronchial Thermoplasty in Severe Asthma (TASMA) Extension Study</brief_title>
	<detailed_description />
	<mesh_term>Asthma</mesh_term>
	<criteria>Subject participation in the TASMA study Ability and willingness to provide informed consent. Ability to comply with the study protocol Subject participating in another clinical trial involving respiratory intervention which in the opinion of the investigator might interfere with the study.</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>November 2016</verification_date>
	<keyword>bronchial thermoplasty</keyword>
	<keyword>long term</keyword>
	<keyword>interventional bronchoscopy</keyword>
</DOC>